Follow
Jing Gu
Title
Cited by
Cited by
Year
The cost-effectiveness of bike lanes in New York City
J Gu, B Mohit, PA Muennig
Injury prevention 23 (4), 239-243, 2017
602017
Lipid treatment status and goal attainment among patients with atherosclerotic cardiovascular disease in the United States: a 2019 update
J Gu, RJ Sanchez, A Chauhan, S Fazio, ND Wong
American journal of preventive cardiology 10, 100336, 2022
222022
Productivity growth of skilled nursing facilities in the treatment of post-acute-care-intensive conditions
J Gu, N Sood, A Dunn, J Romley
PloS one 14 (4), e0215876, 2019
102019
The association of vertically integrated care with health care use and outcomes
PJ Huckfeldt, J Gu, JJ Escarce, P Karaca‐Mandic, N Sood
Health services research 56 (5), 817-827, 2021
42021
The effects of accountable care organizations forming preferred skilled nursing facility networks on market share, patient composition, and outcomes
J Gu, P Huckfeldt, N Sood
Medical care 59 (4), 354-361, 2021
32021
Modelling the potential long-term survival benefit of evinacumab treatment vs. standard of care in patients with homozygous familial hypercholesterolaemia
J Gu, A Kuznik, P Quon, A Chauhan, TS Sravya, FJ Raal
European Journal of Preventive Cardiology 30 (17), 1874-1880, 2023
22023
Simulation of lipid-lowering therapy (LLT) intensification in very high-risk patients with atherosclerotic cardiovascular disease
J Gu, RJ Sanchez, A Chauhan, S Fazio, RS Rosenson
Journal of Clinical Lipidology 16 (6), 901-905, 2022
22022
PCN204 DO PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) RECEIVE TREATMENTS CONSISTENT WITH NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) GUIDELINES AND WHAT ARE THE TOTAL …
TM To, J Gu, J Li, M Schulz, AS Masaquel
Value in Health 22, S94, 2019
22019
Value of germline multi-gene panel next generation sequencing (NGS) in identification of hereditary cancer syndromes (HCS) in colorectal cancer population (CRC).
J Gu, C Ricker, A Barzi
Journal of Clinical Oncology 36 (15_suppl), 1587-1587, 2018
22018
Current treatments for the management of homozygous familial hypercholesterolemia: a systematic review and commentary
J Gu, RN Gupta, H Cheng, Y Xu, FJ Raal
European Journal of Preventive Cardiology, zwae144, 2024
2024
A machine-learning algorithm using claims data to identify patients with homozygous familial hypercholesterolemia
J Gu, M Epland, X Ma, J Park, RJ Sanchez, Y Li
Scientific Reports 14 (1), 8890, 2024
2024
Systematic review on the efficacy of current treatments for the management of homozygous familial hypercholesterolaemia
R Gupta, H Cheng, J Gu, Y Xu, F Raal
Atherosclerosis 379, S68, 2023
2023
A Machine-Learning Algorithm using Claims Data to Identify Patients with Homozygous Familial Hypercholesterolemia (HoFH)
J Gu, X Ma, M Epland, J Park, RJ Sanchez, Y Li
Journal of Clinical Lipidology 17 (4), e24, 2023
2023
PCN51 A COST-EFFCTIVENESS ANALYSIS OF PEMBROLIZUMAB PLUS AXITINIB VERSUS SUNITINIB FOR FIRST-LINE TREATMENT OF ADVANCED RENAL CELL CARCINOMA
J Gu
Value in Health 23, S32, 2020
2020
Productivity Growth of Skilled Nursing Facilities in Treating Post-Acute-Care-Intensive Conditions
J Gu, JA Romley, N Sood
Value in Health 21, S104, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–15